(Circulation. 2004;110:e40-e46.)
© 2004 American Heart Association, Inc.
Clinician Update |
From the Division of Cardiac Surgery, Toronto General Hospital (S.V., P.E.S., R.D.W.), St. Michaels Hospital (D.B., D.L., L.E., Y.L.), and Sunnybrook and Womens College Health Sciences Centre (S.E.F.), University of Toronto, Toronto, Canada.
Correspondence to Subodh Verma, MD, PhD, Division of Cardiac Surgery, Toronto General Hospital, 14 EN-215, 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada. E-mail subodh.verma{at}sympatico.ca
| Introduction |
|---|
|
|
|---|
CABG is the standard surgical procedure for the treatment of advanced coronary artery disease. Since the first successful results reported by Favaloro,1 CABG surgery has been demonstrated to improve symptoms and, in specific subgroups of patients, to prolong life.2 Despite its success, the long-term outcome of coronary bypass surgery is strongly influenced by the fate of the vascular conduits used. Five to 7 years after surgery, patients are at increased risk of suffering from ischemic complications coincident with graft failure.2 Furthermore, as patients undergoing CABG surgery become older with more preoperative risk factors, and treated patients are living longer and therefore requiring reoperation, the optimal selection of vascular grafts for bypass is essential.
| Conduits Used in Bypass Surgery |
|---|
|
|
|---|
The use of arterial conduits has expanded beyond the LITA to include the right internal thoracic artery (RITA), the right gastroepiploic artery (RGEA), the inferior epigastric artery (IEA), and the radial artery (RA). Bilateral ITAs, using the RITA as a pedicled or free graft, have been demonstrated to have long-term patency exceeding SV grafts and result in improved patient survival.1114 However, no randomized trials have been done. The use of bilateral ITAs is commonly avoided in elderly, obese, or diabetic patients, characteristics common to CABG patients, because of higher rates of sternal infection, dehiscence, and mediastinitis.15 The RGEA, primarily used as an in situ graft to bypass the RCA and its branches, has shown reasonable long-term patency that exceeds 90% up to 5 years postoperatively.16,17 Its use, however, has been limited because of the fragile quality of the artery, the small diameter of the vessel at the site of distal anastomosis, concerns regarding vessel twisting, increased operative time, and incisional discomfort with associated ileus. The IEAs, used in composite arterial conduits or as free grafts,1820 are limited primarily by their short usable length, only making them suitable as grafts to diagonal or intermediate branches. The principle adverse events associated with IEA harvesting are related to wound complications such as abdominal wall hematoma or infection, and relative contraindications to their use include obesity, lower abdominal surgery, or coexisting illness potentially requiring abdominal surgery. Thus, despite improved graft patency, multiple arterial conduits have not gained wider acceptance for myocardial revascularization because of increased operative time, limited access to distal coronary sites because of graft length, and patient factors that preclude their use. The final arterial conduit used, the radial artery, which is the focus of this review, overcomes many of these disadvantages.
| Radial Arteries for CABG: Historical Perspective |
|---|
|
|
|---|
In 1992, Acar and colleagues24 reported the results from 104 patients who received a RA graft as a bypass conduit since 1989. The study showed that the RA is a reasonable alternative to other types of conduits to complement the LITA. Notably, in contrast to initial attempts, early RA patency was 100% in this modern experience, likely because of modifications that reduced endothelial damage and graft spasm.
Three major modifications are now used to minimize RA spasm, the primary cause of early graft failure. First, the RA is harvested as a pedicle, including 2 satellite veins and the surrounding fatty tissue, using an atraumatic "no-touch" technique similar to that used in the harvest of other arterial conduits for coronary surgery (see the Figure).25,26 During harvesting, direct handling of the RA is avoided. Second, mechanical dilation of the graft has been replaced by pharmacological dilation with papaverine, a phosphodiesterase III inhibitor that enhances the nitric oxide pathway, minimizing endothelial damage and dysfunction. Third, in hopes of minimizing postoperative RA spasm, vasodilator therapy, most commonly with calcium channel blockers or nitrates, has been adopted, despite limited clinical outcome data to support this practice.
|
| Potential Advantages of Radial Artery Use |
|---|
|
|
|---|
When compared with other vascular conduits, the RA provides additional benefits. According to observational studies, relative to SV grafts, RAs can be harvested without interfering with ambulation and their use has been shown to be protective against both early and late mortality and morbidity,28 resulting in enhanced late survival.29 Also, unlike SV grafts, RA grafts are adapted to higher arterial pressures and have a homogeneous caliber free from internal valves, characteristics possibly contributing to the RAs superior results. Compared with other arterial grafts, contraindications such as obesity, diabetes mellitus, or previous laparotomy do not apply to RA harvesting, allowing this conduit to be harvested in a majority of patients. When comparing the RITA to the RA as a second arterial graft, patients receiving a RA have a lower incidence of sternal wound infection and decreased transfusion requirement, though there is no difference in perioperative or intermediate-term cardiac morbidity or mortality rates.30 Furthermore, RA use is safe in patients with moderate to severe left ventricular dysfunction31 and in patients over the age of 6532 (see Table 1).
|
| Potential Disadvantages of Radial Artery Use |
|---|
|
|
|---|
The major disadvantage, which may affect long-term performance, is the propensity of the RA to go into spasm. RA graft spasm is more intense and more difficult to reverse compared with spasm of the internal thoracic artery.38 Basic science investigations have elucidated the mechanism by which RA spasm is mediated. Although nonreceptor-mediated spasm in response to surgical trauma and local tissue acidity is important, it is the receptor-mediated response to catecholamines and platelet-derived factors, induced by endothelial damage and platelet aggregation, which should be abrogated in the setting of a coronary bypass graft. Endothelial function of the RA, in terms of the release of endothelium-derived relaxing factors such as nitric oxide, is similar to that of other arteries, as is its sensitivity to vasoconstricting agents.38 Thus, the propensity for the RA to go into spasm is likely due to the higher density of muscle cells in the media of this vessel that are organized into multiple tight layers, whereas the internal thoracic, gastroepiploic, and epigastric arteries have fewer muscle cells that are less organized.27 Because of the more muscular nature of the RA, a significantly higher maximal contractile force can result in response to vasoconstricting agents, such as norepinephrine, serotonin, endothelin I, and angiotensin II, generated in response to endothelial damage and dysfunction.33,38 Thus, use of the RA as a bypass conduit in patients at high risk of needing postoperative vasopressor support should be avoided. Currently, the propensity of the RA to spasm has been greatly reduced by minimal touch harvesting, pharmacological dilation, and the use of both topical and systemic vasodilators, including calcium channel blockers,24,30 papaverine,24 the phosphodiesterase inhibitor milrinone,34 intravenous nitroglycerin,39 and
-adrenergic receptor blockers.40 Finally, studies suggest that the RA should be limited to grafting native vessels with a high degree of stenosis (>70%) because of graft sensitivity to competitive flow and its increased propensity to spasm.41
| Patency Rates of Radial Artery Conduits |
|---|
|
|
|---|
|
The RAPCO study was undertaken to compare elective angiographic patency and cardiac event-free survival of the RA graft with that of the free RITA or SV during a 10-year period after primary CABG surgery. The RA was compared with the free RITA in a younger patient group (n=285, age <70 years) and with the SV in an older patient group (n=153, age
75 years). Patients were randomly assigned to receive either the RA, RITA, or SV grafted to the largest available coronary artery other than the LAD. The 5-year interim results of this prospective, randomized, single-center trial were recently reported.45 Buxton and colleagues45 report that in the first 5 years after surgery, there were no differences in the angiographic failure rates and major clinical outcomes, namely survival and cardiac event-free survival, of the RA compared with the RITA or SV. However, these results were based on only a small proportion of the expected angiographic results. Furthermore, in their study,45 SV graft patency rates were much better than those previously recorded or the nonstudy SVs. Also, the 5-year time point may be too short to assess the true difference in patency as SV grafts begin to display accelerated graft atherosclerosis and increasing rates of graft failure between 5 and 10 years postoperatively. Thus, the final results obtained after 10 years of follow-up should help clarify the long-term RA patency rates and whether the use of this graft in CABG is superior to the RITA or SV.
The results of the second trial, RAPS,46 were reported at the 2003 American Heart Association Scientific Sessions.57 RAPS was a prospective, multicenter, randomized clinical trial comparing RA patency with that of the SV when randomly allocated as the graft to the right or circumflex coronary arteries. The primary objective of the study was to determine the 8- to 12-month angiographic patency of the RA relative to the SV, with each patient serving as his or her own control. The long-term patency (5 to 10 years) of the RA relative to SV grafts will be assessed in follow-up studies. A total of 561 patients were enrolled, of whom 440 underwent follow-up angiography. Graft patency was greater in RA grafts (91.8%) than in SV grafts (86.4%, P=0.01; graft occlusion odds ratio =0.53, 95% confidence interval 0.31 to 0.85). Perfect graft patency, defined as grafts with Thrombolysis In Myocardial Infarction (TIMI) 3 flow, was similar (87.7% versus 85.7%, P=0.37). Perfect patency of the radial artery was highly dependent on the severity of the proximal native coronary artery stenosis (70% to 89% coronary stenosis: 81.7%;
90% coronary stenosis: 91.5%). Patency of the RA graft was similar in the RCA and circumflex territories.
| The Future of the Radial Artery as a Vascular Conduit |
|---|
|
|
|---|
Mr P was deemed eligible for CABG. Because of his age, the use of arterial grafts was preferred. However, his obesity, diabetes, and previous laparotomy prompted the surgeons to avoid harvesting the RITA, IEA, and RGEA. His right Allen test was sluggish; however, it was normal on the left. Therefore, Mr P underwent CABG with a LITA to the LAD, a left radial artery graft to the distal RCA, and a SV graft to the first obtuse marginal branch, similar to the procedure illustrated in the Figure. His perioperative course was unremarkable and he was discharged from hospital 5 days after surgery.
Note Added in Proof
During the review process, an important article on radial arteries was published by Zacharias et al.63 The authors evaluated 6-year outcomes in propensity-matched CABG-LITA-LAD patients (925 each) divided into those with one radial graft and those with vein-only grafting. Perioperative outcomes, including death, were similar, although cumulative survival was better for patients receiving the radial artery graft. Angiography data in restudied symptomatic patients showed a trend for greater radial artery graft patency. Furthermore, the extent of vein graft failure was significantly worse than that of radial graft falure. These data would support the use of radial arteries as a second arterial conduit in CABG-LITA-LAD as opposed to vein grafting.
| References |
|---|
|
|
|---|
2. Kirklin JW, Akins CW, Blackstone EH, et al. ACC/AHA Task Force report: guidelines and indications for coronary artery bypass graft surgery. J Am Coll Cardiol. 1991; 17: 543589.[Medline] [Order article via Infotrieve]
3. Fremes SE, Levinton C, Naylor CD, et al. Optimal antithrombotic therapy following aortocoronary bypass: a metaanalysis. Eur J Cardiothorac Surg. 1993; 7: 169180.[Abstract]
4. Bourassa MG, Fisher LD, Campeau L, et al. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation. 1985; 72 (Suppl V): V71V78.[Medline] [Order article via Infotrieve]
5. Lytle BW, Loop FD, Cosgrove DM, et al. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985; 89: 248258.[Abstract]
6. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986; 314: 16.[Abstract]
7. Cameron A, Davis KB, Green G, et al. Coronary bypass surgery with internal-thoracic-artery grafts: effects on survival over a 15-year period. N Engl J Med. 1996; 334: 216219.
8. Zeff RH, Kongtahworn C, Iannone LA, et al. Internal mammary artery versus saphenous vein graft to the left anterior descending coronary artery: prospective randomized study with 10-year follow-up. Ann Thorac Surg. 1988; 45: 533536.[Abstract]
9. Boylan MJ, Lytle BW, Loop FD, et al. Surgical treatment of isolated left anterior descending coronary stenosis. J Thorac Cardiovasc Surg. 1994; 107: 657662.
10. Muneretto C, Negri A, Manfredi J, et al. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg. 2003; 125: 826835.
11. Fiore AC, Naunheim KS, Dean P, et al. Results of internal thoracic artery grafting over 15 years: single versus double grafts. Ann Thorac Surg. 1990; 49: 202209.[Abstract]
12. Cameron AAC, Green GE, Brogno DA, et al. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cardiol. 1995; 25: 188192.[Abstract]
13. Schmidt SE, Jones JW, Thornby JI, et al. Improved survival with multiple left-sided bilateral internal thoracic artery grafts. Ann Thorac Surg. 1997; 64: 915.
14. Tatoulis J, Buxton BF, Fuller JA. Results of 1454 free right internal thoracic artery-to-coronary artery grafts. Ann Thorac Surg. 1997; 64: 12631269.
15. Kouchoukos NT, Wareing TH, Murphy SF, et al. Risks of bilateral internal mammary artery bypass grafting. Ann Thorac Surg. 1990; 49: 210219.[Abstract]
16. Suma H, Wanibuchi Y, Terada Y, et al. The right gastroepiploic artery graft: clinical and angiographic midterm results in 200 patients. J Thorac Cardiovasc Surg. 1993; 105: 615623.[Abstract]
17. Bergsma TM, Grandjean JG, Voors AA et al. Low recurrence of angina pectoris after coronary artery bypass graft surgery with bilateral internal thoracic and right gastroepiploic arteries. Circulation. 1998; 97: 24022405.
18. Puig LB, Ciogolli W, Cividanes GL, et al. Inferior epigastric artery as a free graft for myocardial revascularization. J Thorac Cardiovasc Surg. 1990; 99: 251255.[Abstract]
19. Barner HB, Naunheim KS, Fiore AC, et al. Use of inferior epigastric artery as a free graft for myocardial revascularization. Ann Thorac Surg. 1991; 52: 429437.[Abstract]
20. Calafiore AM, Di Giammarco G, Teodori G, et al. Radial artery and inferior epigastric artery in composite grafts: improved midterm angiographic results. Ann Thorac Surg. 1995; 60: 517524.
21. Carpentier A, Guermonprez JL, Deloche A, et al. The aorta-to-coronary radial artery bypass graft: a technique avoiding pathological changes in grafts. Ann Thorac Surg. 1973; 16: 111121.[Medline] [Order article via Infotrieve]
22. Curtis JJ, Stoney WS, Alford WC, et al. Intimal hyperplasia: a cause of radial artery aortocoronary bypass graft failure. Ann Thorac Surg. 1975; 20: 628635.[Abstract]
23. Fisk RL, Brooks CH, Callaghan JC, et al. Experience with the radial artery graft for coronary artery bypass. Ann Thorac Surg. 1976; 21: 513518.[Abstract]
24. Acar C, Jebara VA, Portoghese M, et al. Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg. 1992; 54: 652660.[Abstract]
25. Reyes AT, Frame R, Brodman RF. Technique for harvesting the radial artery as a coronary artery bypass graft. Ann Thorac Surg. 1995; 59: 118126.
26. Fremes SE, Christakis GT, Del Rizzo DF, et al. The technique of radial artery bypass grafting and early clinical results. J Card Surg. 1995; 10: 537544.[Medline] [Order article via Infotrieve]
27. van Son JAM, Smedts F, Vincent JG, et al. Comparative anatomic studies of various arterial conduits for myocardial revascularization. J Thorac Cardiovasc Surg. 1990; 99: 703707.[Abstract]
28. Cohen G, Tamariz MG, Sever JY, et al. The radial artery versus the saphenous vein graft in contemporary CABG: a case-matched study. Ann Thorac Surg. 2001; 71: 180186.
29. Hata M, Seevanayagam S, Manson N, et al. Radial artery 2000: risk analysis of mortality for coronary bypass surgery with radial artery. Ann Thorac Cardiovasc Surg. 2002; 8: 354357.[Medline] [Order article via Infotrieve]
30. Borger MA, Cohen G, Buth KJ, et al. Multiple arterial grafts: radial versus right internal thoracic arteries. Circulation. 1998; 98 (suppl): II7II14.[Medline] [Order article via Infotrieve]
31. Fazel S, Mallidi HR, Pelletier MP, et al. Radial artery use is safe in patients with moderate to severe left ventricular dysfunction. Ann Thorac Surg. 2003; 75: 14141421.
32. Modine T, Al-Ruzzeh S, Mazrani W, et al. Use of radial artery graft reduces the morbidity of coronary artery bypass graft surgery in patients aged 65 years and older. Ann Thorac Surg. 2002; 74: 11441147.
33. Parolari A, Rubini P, Alamanni F, et al. The radial artery: which place in coronary operation? Ann Thorac Surg. 2000; 69: 12881294.
34. Tatoulis J, Buxton BF, Fuller JA. Bilateral radial artery grafts in coronary reconstruction: technique and early results in 261 patients. Ann Thorac Surg. 1998; 66: 714720.
35. Greene MA, Malias MA. Arm complications after radial artery procurement for coronary bypass operation. Ann Thorac Surg. 2001; 72: 126128.
36. Budillon AM, Nicolini F, Agostinelli A, et al. Complications after radial artery harvesting for coronary artery bypass grafting: our experience. Surgery. 2003; 133: 283287.[CrossRef][Medline] [Order article via Infotrieve]
37. Kaufer E, Factor SM, Frame R, et al. Pathology of the radial and internal thoracic arteries used as coronary artery bypass grafts. Ann Thorac Surg. 1997; 63: 11181122.
38. Chardigny C, Jebara VA, Acar C, et al. Vasoreactivity of the radial artery: comparison with the internal mammary artery and gastroepiploic arteries with implications for coronary artery surgery. Circulation. 1993; 88 (suppl II): II115II127.[Medline] [Order article via Infotrieve]
39. Zabeeda D, Medalion B, Jackobshvilli S, et al. Comparison of systemic vasodilators: effects on flow in internal mammary and radial arteries. Ann Thorac Surg. 2001; 71: 138141.
40. Taggart DP, Dipp M, Mussa S, et al. Phenoxybenzamine prevents spasm in radial artery conduits for coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000; 120: 815817.
41. Maniar HS, Sundt TM, Barner HB, et al. Effect of target stenosis and location on radial artery graft patency. J Thorac Cardiovasc Surg. 2002; 123: 4552.
42. Calafiore AM, Di Mauro M, DAlessandro S, et al. Revascularization of the lateral wall: long-term angiographic and clinical results of radial artery versus right internal thoracic artery grafting. J Thorac Cardiovasc Surg. 2002; 123: 225231.
43. Weinschelbaum EE, Gabe ED, Macchia A, et a;. Total myocardial revascularization with arterial conduits: radial artery combined with internal thoracic arteries. J Thorac Cardiovasc Surg. 1997; 114: 911916.
44. Iaco AL, Teodori G, Di Giammarco G, et al. Radial artery for myocardial revascularization: long-term clinical and angiographic results. Ann Thorac Surg. 2001; 72: 464469.
45. Buxton BF, Raman JS, Ruengsakulrach P, et al. Radial artery patency and clinical outcomes: five-year interim results of a randomized trial. J Thorac Cardiovasc Surg. 2003; 125: 13631367.
46. Fremes SE. Multicenter radial artery patency study (RAPS). Study design. Control Clin Trials. 2000; 21: 397413.[CrossRef][Medline] [Order article via Infotrieve]
47. Calafiore AM, Di Giammarco G, Luciani N, et al. Composite arterial conduits for a wider arterial myocardial revascularization. Ann Thorac Surg. 1994; 58: 185190.[Abstract]
48. Chen AH, Nakao T, Brodman RF, et al. Early postoperative angiographic assessment of radial artery grafts used for coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996; 111: 12081212.
49. da Costa FD, da Costa IE, Poffo R, et al. Myocardial revascularization with the radial artery: a clinical and angiographic study. Ann Thorac Surg. 1996; 62: 475480.
50. Brodman RF, Frame R, Camacho M, et al. Routine use of unilateral and bilateral radial arteries for coronary artery bypass graft surgery. J Am Coll Cardiol. 1996; 28: 959963.[Abstract]
51. Amano A, Hirose H, Takahashi A, et al. Coronary artery bypass grafting using the radial artery: midterm results in a Japanese institute. Ann Thorac Surg. 2001; 72: 120125.
52. Manasse E, Sperti G, Suma H, et al. Use of the radial artery for myocardial revascularization. Ann Thorac Surg. 1996; 62: 10761083.
53. Bhan A, Gupta V, Choudhary SK, et al. Radial artery in CABG: could the early results be comparable to internal mammary artery graft? Ann Thorac Surg. 1999; 67: 16311636.
54. Acar C, Ramsheyi A, Pagny JY, et al. The radial artery for coronary artery bypass grafting: clinical and angiographic results at five years. J Thorac Cardiovasc Surg. 1998; 116: 981989.
55. Possati G, Gaudino M, Alessandrini F, et al. Midterm clinical and angiographic results of radial artery grafts used for myocardial revascularization. J Thorac Cardiovasc Surg. 1998; 116: 10151021.
56. Possati G, Gaudino M, Prati F, et al. Long-term results of the radial artery used for myocardial revascularization. Circulation. 2003; 108: 13501354.
57. Desai ND, Cohen EA, Fremes SE. One year results of the multi-centre radial artery patency study. Circulation. 2003; 108 (suppl IV): IV-390. Abstract.
58. Kobayashi J, Tagusari O, Bando K, et al. Total arterial off-pump coronary revascularization with only internal thoracic artery and composite radial artery grafts. Heart Surg Forum. 2002; 6: 3037.[Medline] [Order article via Infotrieve]
59. Tanaka H, Narisawa T, Mori N, et al. The left internal thoracic artery and radial artery composite graft in off-pump coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2002; 8: 204208.[Medline] [Order article via Infotrieve]
60. Arom KV, Jotisakulratana V, Pitiguagool V, et al. Technique of using the St. Jude aortic connector with the radial artery. Ann Thorac Surg. 2003; 76: 633634.
61. Cable DG, Caccitolo JA, Pearson PJ, et al. New approaches to prevention and treatment of radial artery graft vasospasm. Circulation. 1998; 98 (suppl): II15II22.[Medline] [Order article via Infotrieve]
62. Casula RP, Kumar P, Ashrafian H, Athanasiou T. Evolving techniques for endoscopic radial artery harvesting. Cardiovasc Surg. 2003; 11: 425427.[CrossRef][Medline] [Order article via Infotrieve]
63. Zacharias A, Habib RH, Schwann TA, et al. Improved survival with radial artery versus vein conduits in coronary bypass surgery with left internal thoracic artery to left anterior descending artery grafting. Circulation. 2004; 109: 14891496.
Related Article:
Circulation 2004 110: 471.
This article has been cited by other articles:
![]() |
J. Tatoulis, B. F. Buxton, J. A. Fuller, M. Meswani, S. Theodore, N. Powar, and R. Wynne Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. Ann. Thorac. Surg., July 1, 2009; 88(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Singh, N. D. Desai, S. D. Petroff, S. Deb, E. A. Cohen, S. Radhakrishnan, L. Schwartz, J. Dubbin, S. E. Fremes, and for the Radial Artery Patency Study Investigators The Impact of Diabetic Status on Coronary Artery Bypass Graft Patency: Insights From the Radial Artery Patency Study Circulation, September 30, 2008; 118(14_suppl_1): S222 - S225. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Collins, C. M. Webb, C. F. Chong, N. E. Moat, and for the Radial Artery Versus Saphenous Vein Patenc Radial Artery Versus Saphenous Vein Patency Randomized Trial: Five-Year Angiographic Follow-Up Circulation, June 3, 2008; 117(22): 2859 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Onorati, F. Pezzo, M. C. Comi, B. Impiombato, A. Esposito, M. Polistina, and A. Renzulli Radial artery graft function is not affected by age. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1112 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A.R. Hayward and B. F. Buxton Contemporary Coronary Graft Patency: 5-Year Observational Data From a Randomized Trial of Conduits Ann. Thorac. Surg., September 1, 2007; 84(3): 795 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawatsu, K. Oda, Y. Saiki, Y. Tabata, and K. Tabayashi External Application of Rapamycin-Eluting Film at Anastomotic Sites Inhibits Neointimal Hyperplasia in a Canine Model Ann. Thorac. Surg., August 1, 2007; 84(2): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gardner Searching for the Second-Best Coronary Artery Bypass Graft: Is It the Radial Artery? Circulation, February 13, 2007; 115(6): 678 - 680. [Full Text] [PDF] |
||||
![]() |
D. G.M. Molin and M. J. Post Do intrinsic arterial wall features determine atherosclerosis susceptibility? Cardiovasc Res, October 1, 2006; 72(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
D. G. Nezic, A. M. Knezevic, P. S. Milojevic, B. P. Dukanovic, M. D. Jovic, M. D. Borzanovic, and A. N. Neskovic The fate of the radial artery conduit in coronary artery bypass grafting surgery. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputo, P. Narayan, and G. D. Angelini Conventional surgery with aortic cross-clamping MMCTS, March 15, 2006; 2006(0315): 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 651 - 658. |
||||
![]() |
M. R. Hoenig, G. R. Campbell, B. E. Rolfe, and J. H. Campbell Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts? Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |